Citing testing after the CDC's failed initial test reagents is not painting a whole picture of care capability. The testing will catch up in the US. What isn't

Citing testing after the CDC's failed initial test reagents is not painting a whole picture of care capability. The testing will catch up in the US. What isn't easy to scale is the critical care of patients who are hardest hit. That is a capability which the US excels in: [1] USA has 34.7 ICU Beds / 100K [2] Canada has 9.5 ICU Beds / 100K [1]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351597/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351597/ [2]: https://www.researchgate.net/publication/275101876_Critical_Care_capacity_in_Canada_results_of_a_national_cross-sectional_study https://www.researchgate.net/publication/275101876_Critical_...